In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Mobic (Boehringer Ingelheim)
- INDICATIONS: Osteoarthritis
- CLASS: COX-2 inhibitor, Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 15–20 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aliskiren, Alpha blockers, Angiotensin II receptor antagonists, Anticoagulants, Antidepressants, Antiplatelet agents, Aspirin, Baclofen, Beta blockers, Bile acid sequestrants, Calcium channel blockers, Cardiac glycosides, Cholestyramine, Clonidine, Clopidogrel, Collagenase, Conivaptan, Corticosteroids, Coumarins, Cyclosporine, Dabigatran, Dasatinib, Desmopressin, Diazoxide, Digoxin, Diuretics, Drotrecogin Alfa, Eplerenone, Erlotinib, Glucosamine, Haloperidol, Heparins, Hydralazine, Ibritumomab, Iloprost, Ketorolac, Lithium, Methotrexate, Methyldopa, Mifamurtide, Minoxidil, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Pemetrexed, Penicillamine, Pentosan, Pentoxifylline, Phenindione, Pralatrexate, Prasugrel, Probenecid, Prostacyclin analogues, Quinolones, Ritonavir, Serotonin/norepinephrine reuptake inhibitors, SSRIs, Sulfonylureas, Tacrolimus, Thrombolytic agents, Tositumomab & Iodine131, Treprostinil, Vancomycin, Venlafaxine, Vitamin K antagonists, Voriconazole, Zidovudine - PREGNANCY: category D from 30 weeks gestation
- See adverse reactions attributed to class:
NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
CARDIOVASCULAR AND GASTROINTESTINAL RISKS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 07/04/2024
